Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) Sees Large Growth in Short Interest

Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) saw a large growth in short interest during the month of October. As of October 31st, there was short interest totalling 123,200 shares, a growth of 27.1% from the October 15th total of 96,900 shares. Approximately 0.7% of the shares of the stock are sold short. Based on an average trading volume of 120,900 shares, the short-interest ratio is presently 1.0 days.

Inspira Technologies Oxy B.H.N. Price Performance

IINN traded down $0.07 during trading on Friday, reaching $1.18. The company had a trading volume of 116,554 shares, compared to its average volume of 442,285. Inspira Technologies Oxy B.H.N. has a 12-month low of $0.76 and a 12-month high of $2.49. The firm’s 50-day simple moving average is $1.31 and its 200 day simple moving average is $1.46. The company has a current ratio of 2.23, a quick ratio of 2.13 and a debt-to-equity ratio of 0.09.

Institutional Investors Weigh In On Inspira Technologies Oxy B.H.N.

A hedge fund recently bought a new stake in Inspira Technologies Oxy B.H.N. stock. Renaissance Technologies LLC acquired a new stake in Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 24,497 shares of the company’s stock, valued at approximately $34,000. Renaissance Technologies LLC owned 0.19% of Inspira Technologies Oxy B.H.N. at the end of the most recent quarter. Institutional investors and hedge funds own 12.72% of the company’s stock.

About Inspira Technologies Oxy B.H.N.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.